DRTS Alpha Tau Medical Ltd.

Nasdaq alphatau.com


$ 3.97 $ -0.16 (-3.81 %)    

Wednesday, 22-Oct-2025 16:11:30 EDT
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 4.04
$ 4.27
$ 3.97 x 32
$ 4.99 x 100
$ 3.97 - $ 4.27
$ 2.14 - $ 4.69
38,413
na
281.47M
$ 1.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

 alpha-tau-medical-q2-eps-013-misses-012-estimate

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $...

 alpha-tau-medical-1h-eps-025
Alpha Tau Medical 1H EPS $(0.25)
08/11/2025 20:19:50

 alpha-tau-medical-q1-eps-012-beats-013-estimate

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0...

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

Core News & Articles

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

 alpha-tau-granted-fda-approval-to-initiate-trial-for-patients-with-recurrent-glioblastoma

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW))), the developer of the innovative al...

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

 alpha-tau-receives-medical-device-single-audit-program-certification

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

 alpha-tau-announces-upcoming-presentation-of-an-abstract-entitled-interim-analysis-of-feasibility-safety-and-tumor-control-in-two-first-in-human-trials-of-a-novel-alpha-emitting-radionuclide-for-pancreatic-adenocarcinoma-at-2025-asco-gi-symposium-and-at-company-rd-update-day

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

 alpha-tau-medical-q3-eps-010-beats-013-estimate

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0...

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

 hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

 alpha-tau-treats-first-patient-with-recurrent-lung-cancer-in-a-clinical-trial-at-hadassah-medical-center-in-jerusalem-israel

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)))), the developer of the innovative...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION